Under-the-tongue Tirzepatide and Semaglutide Drops
Willow previously sold under-the-tongue Tirzepatide and Semaglutide Drops, but there are no FDA-approved GLP-1 drops.
Semaglutide Tablets
Willow admits that its Semaglutide Tablets have not undergone clinical trials to test weight loss efficacy.
Products Under Investigation
Consumers complain that Willow's products are ineffective
Approximately one-third of Willow's reviews on Trust Pilot are one star.
Redditors question the effectiveness of Willow's products.
The Better Business Bureau refers Willow to regulatory agencies regarding Willow's advertising for its Semaglutide products
Read the announcement here.
Willow stops selling oral GLP-1 drops after it is sued by pharmaceutical manufacturer Eli Lilly for false advertising
Willow previously sold GLP-1 oral drops, but stopped selling them after pharmaceutical manufacturer Eli Lilly sued Willow for false advertising.
Eli Lilly's lawsuit was dismissed for procedural reasons.
However, consumers who purchased Willow products based on false or misleading claims about their effectiveness may be able to pursue legal claims against Willow.
Consumers misled by Willow's advertising who wish to pursue legal remedies may be required to do so in California
Willow's terms of service dictate that "[a]ll claims, legal proceedings, or litigation arising in connection with the Services will be brought solely in the federal or state courts located in Los Angeles County, California."
Contact California law firms Barrientos PC and Mayberry Law
DISCLAIMER: The information on this site is not legal advice. You should consult an attorney for advice regarding your individual situation. While Barrientos PC and Mayberry Law welcome your submissions, contacting Barrientos PC does not alone create an attorney-client relationship. Please do not send any confidential information to Barrientos PC until an attorney-client relationship has been established through a formal agreement. Barrientos PC and Mayberry Law do not, and cannot, guarantee any outcome.